None of the published data [13, 23, 24] included PSMA ligand PET staging for MDT that led to MDT at higher PSA levels, particularly increasing the likelihood that patients had an underestimated extent of lymph node metastases [11, 22]. The gene discussed is KLK3; the disease is metastatic malignant neoplasm in the lymph nodes.